Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

CNS 1

Conditions

Sarcoma 6Rhabdomyosarcoma 3Sarcoma, Ewing 2Osteosarcoma 2Neuroectodermal Tumors, Primitive, Peripheral 2Leukemia, Myeloid, Acute 2Breast Neoplasms 2Sarcoma, Synovial 1Sarcoma, Myeloid 1Rhabdoid Tumor 1Neurofibrosarcoma 1Neuroblastoma 1Myeloproliferative Disorders 1Myelodysplastic Syndromes 1Malignant mesenchymal tumor 1Liposarcoma 1Leiomyosarcoma 1Histiocytoma, Malignant Fibrous 1Hemangiosarcoma 1Ganglioneuroblastoma 1Fibrosarcoma 1Dermatofibrosarcoma 1Central Nervous System Neoplasms 1Cardiotoxicity 1Blast Crisis 1

Interventions

Magnetic Resonance Spectroscopy 7X-Rays 6Phantoms, Imaging 6Cyclophosphamide 6Specimen Handling 5Nuclear Medicine Department, Hospital 5Topotecan 4Etoposide 4Biopsy 4palbociclib 3Vincristine 3Methotrexate 3Cisplatin 3ulixertinib 2tipifarnib 2tazemetostat 2selpercatinib 2olaparib 2larotrectinib 2ivosidenib 2etoposide phosphate 2erdafitinib 2ensartinib 2Vemurafenib 2Temozolomide 2Radiotherapy 2Nivolumab 2LY3023414 2Carboplatin 2selinexor 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Rhabdoid Tumor × Dexrazoxane × Clear all
NCT00084838 2015-12-24

Chemotherapy Combined With Radiation Therapy for Newly Diagnosed CNS AT/RT

Dana-Farber Cancer Institute

Phase 2 Completed
25 enrolled 24 charts
CNS

Central Nervous System Neoplasms, Rhabdoid Tumor

Data powered by HemOnc (CC BY 4.0) Colophon âš¡